
Reset all filters
01 1Orion Corporation
02 1AOP Health
03 3Accord healthcare
04 2Actavis Inc
05 1Aristo Pharma GmbH
06 1Aurobindo Pharma Limited
07 1Aurovitas Spain, Sau
08 1Avansor Pharma Oy
09 2BARR LABS
10 2Bluefish Pharmaceuticals AB
11 2Chartwell Pharmaceuticals llc
12 2Cipla
13 1Farm Agon
14 1Farmatek
15 1GSK
16 1Glenmark Pharmaceuticals
17 2Impax Laboratories
18 1Key Oncologics
19 2Novitium Pharma LLC
20 1ORIFARM GROUP AS
21 2OrPha Swiss
22 2Pharmascience Inc.
23 1Pharmavic Iberica Sl
24 2ROXANE
25 2Rising Pharmaceuticals Inc
26 2SHIRE PLC
27 2STADA Arzneimittel
28 2Sandoz B2B
29 7Takeda Pharmaceutical
30 3Teva Pharmaceutical Industries
31 4Torrent Pharmaceuticals Limited
32 1Urquima S.A. Grupo Uriach
33 1Uxa Farma Sa
34 3Viatris
Reset all filters
01 1Anagrelide 0.5Mg 100 Unita' Oral Use
02 2CAP
03 3CAPSULE
04 20CAPSULE;ORAL
05 15Capsule
06 3Capsule, hard
07 15Hard Capsule
08 1Hard Capsule For Oral Use
09 3Hard Capsules
Reset all filters
01 3Allowed
02 10Approved
03 8Authorized
04 5Cancelled
05 13DISCN
06 1Deregistered
07 2Generic
08 1Originator
09 2Prescription
10 7RX
11 11Blank
Reset all filters
01 2AGRYLIN
02 1ANAGRELIDE ACCORD
03 18ANAGRELIDE HYDROCHLORIDE
04 1ANAGRELIDE SANDZ
05 1ANAGRELIDE TEVA
06 1ANAGRELIDE VIATRIS
07 1Agrylin 0,5 mg
08 1Anagrelid Accordpharma
09 1Anagrelid Avansor
10 1Anagrelid Orion
11 1Anagrelida Aristo
12 1Anagrelida Aurobindo
13 1Anagrelida Bluefish
14 1Anagrelida Pharmavic
15 1Anagrelida Ratiopharm
16 1Anagrelida Teva
17 1Anagrelide Accordpharma
18 1Anagrelide Aop
19 1Anagrelide Aurovitas
20 1Anagrelide Bluefish
21 2Anagrelide Glenmark
22 1Anagrelide Sandoz
23 2Anagrelide Stada
24 1Anagrelide Uriach
25 2Anagrelide Viatris
26 2PMS-ANAGRELIDE
27 2Thromboreductin
28 1Thromboreductin 0.5mg
29 1Uxabel
30 1XAGRID
31 7Xagrid
32 3Blank
Reset all filters
01 2Canada
02 1India
03 6Italy
04 3Norway
05 2South Africa
06 13Spain
07 11Sweden
08 3Switzerland
09 1Turkey
10 20USA
11 1United Kingdom
Regulatory Info : Approved
Registration Country : Sweden
Anagrelide Hydrochloride Monohydrate
Brand Name : Anagrelid Orion
Dosage Form : Capsule
Dosage Strength : 0.5mg
Packaging :
Approval Date : 07/02/2019
Application Number : 20180309000155
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ANAGRELIDE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2005-04-18
Application Number : 76417
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ANAGRELIDE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 1MG BASE
Packaging :
Approval Date : 2005-04-18
Application Number : 76417
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ANAGRELIDE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2005-04-18
Application Number : 76683
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ANAGRELIDE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 1MG BASE
Packaging :
Approval Date : 2005-04-18
Application Number : 76683
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ANAGRELIDE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2005-04-18
Application Number : 76468
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ANAGRELIDE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 1MG BASE
Packaging :
Approval Date : 2005-04-18
Application Number : 76468
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ANAGRELIDE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2005-04-18
Application Number : 76910
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ANAGRELIDE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 1MG BASE
Packaging :
Approval Date : 2005-04-18
Application Number : 76910
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ANAGRELIDE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2005-04-18
Application Number : 76811
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ANAGRELIDE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 1MG BASE
Packaging :
Approval Date : 2005-04-18
Application Number : 76811
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ANAGRELIDE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2006-06-27
Application Number : 77613
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ANAGRELIDE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 1MG BASE
Packaging :
Approval Date : 2006-06-27
Application Number : 77613
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ANAGRELIDE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2005-04-18
Application Number : 76489
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ANAGRELIDE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 1MG BASE
Packaging :
Approval Date : 2005-04-18
Application Number : 76489
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AGRYLIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 1997-03-14
Application Number : 20333
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : AGRYLIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1997-03-14
Application Number : 20333
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ANAGRELIDE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2017-06-30
Application Number : 209151
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ANAGRELIDE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2005-04-18
Application Number : 76530
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ANAGRELIDE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 1MG BASE
Packaging :
Approval Date : 2005-04-18
Application Number : 76530
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF